My notes on Dr. John Campbell's video "TUESDAY UPDATE" in which he reviews Novavax and a small Ivermectin study in Israel.
youtube.com ^ | Jun 15, 2021 | Dr. John Campbell and vanity
Posted on 6/16/2021, 2:03:15 AM by ransomnote
Dr. Campbell notes that he's reading from a press release and the vaccine research has not been peer reviewed yet.
ransomnote: I was wondering why there were so many news articles for Novavax all dated 6/14. Almost like press releases = free advertising from MSM. I saw elsewhere that Novavax development was also supported by the Bill & Melinda Gates foundation, among others.
How Novavax works:
DNA designed to make the spike proteins is put into another virus and that virus is put into moth cells. The DNA instructs the moth cells to mass produce the spike proteins, then the spike proteins are harvested (purified) from the moth cells.
The spike cells stick together and have the antigenic properties of the Sars 2 Covid virus, without the actual presence of the Covid virus.
ransomnote: Covid spike proteins are causing harm in other vaccines. Inventor Of mRNA Vaccine Technology: Spike Protein Is Dangerous, Its Cytotoxic. The FDA Was Warned About It Months Ago
First case of postmortem study in a patient vaccinated against SARS-CoV-2 [Spike Protein in every organ in his body!] or transcript:
Dr. Mercola Explains Dr. Bridle’s Bombshell Revelations Regarding Spike Proteins from Vaccines
Compared with the mRNA vaccines and DNA 'vaccines', which tell your own body cells to produce the spike protein, the Novavax is designed to directly inject the spike proteins into your body.
The long shot [Novavax Covid Vaccine]
sciencemag.org ^ | 06 Nov 2020: | Meredith Wadman
Posted on 6/15/2021, 11:38:33 PM by ransomnote
SNIP
Eighteen months ago, a small vaccinemaker here called Novavax faced an existential threat: delisting by the NASDAQ stock index. On the heels of a second failed vaccine trial in less than 3 years, the firm's shares had plunged to less than $1 for 30 straight days, triggering a warning by NASDAQ. Frantic to conserve cash, the company sold its two Maryland manufacturing facilities, slicing its payroll by more than 100 employees. By January, it employed only 166 people.
“Good ideas. Bad management. … The company will probably die soon,” a former Novavax manager wrote on Glassdoor.com in October 2019.
What a difference a year—and a pandemic—make. Today, Novavax is slated to receive up to $2 billion from the U.S. government and a nonprofit organization to develop and manufacture a coronavirus vaccine.
SNIP
Novavax's vaccine is made of tiny particles studded with the coronavirus spike protein plus honeycomblike molecules, derived from plants, that stimulate the immune system.
Image of Novavax's tiny particles studded with coronavirus spike proteins
